Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD

NCT05962645 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD
Respiratory Disease
Lower Respiratory Disease
Pulmonary Disease
Healthy

Interventions

DRUG: Vapendavir

Sponsor

Altesa Biosciences, Inc.